Format

Send to

Choose Destination
Arch Intern Med. 2008 Nov 10;168(20):2194-204. doi: 10.1001/archinte.168.20.2194.

Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.

Collaborators (168)

Giannuzzi P, Ceci V, Chieffo C, Gattone M, Griffo R, Marchioli R, Schweiger C, Tavazzi L, Urbinati S, Valagussa F, Vanuzzo D, Giannuzzi P, Maggioni AP, Gattone M, Griffo R, Temporelli PL, Girardini D, Francesconi G, Vona M, Santoni R, Sarno C, Griffo R, Calisi P, Forzoni M, Boncompagni L, Tabouret G, Canci U, Rosato G, Stanco G, Gullace G, Carbone C, Gavazzi A, Mazzoleni D, Pinelli G, Urbinati S, Frizzelli R, Tortelli O, Pantaleoni A, Mantovani E, Pettinati G, Storti G, Chieffo C, Riccio C, Scrutinio D, Passantino A, GuiduccI D, Zobbi G, Vanaria D, Barbanti P, Carini V, Coco R, Borrello G, Mazza ML, Chiesa F, Sansoni C, Morbelli E, Rossi L, Ciglia C, Di Giovanni P, Cocchieri M, Dò V, Trudu A, Albonic D, Bendinelli S, Iori E, Balestra G, Giacometti N, Coppetti S, Priori S, Masotti G, Fattirolli F, Meniconi L, Paolucci P, Malinverni C, Quarenghi F, Fontanelli A, Marini R, Mandorla S, Provvidenza M, Giordano A, De Giuli F, Odoguardi L, Barsotti S, Moccetti T, Molteni A, Mauri F, Lecchi G, Bettini R, Bertoldi A, Zanettini R, Centeleghe P, Corallo S, Rainoldi ML, Ferratini M, Tavanelli M, Leonetti G, Malfatto G, Pascotto P, Zanocco A, Buchberger R, Masaro G, Cobelli F, Riccardi G, Valagussa F, Sala L, Musca G, Cauteruccio MA, Vigorito C, Giallauria F, Mininni N, Morra P, Castello A, Sarullo FM, Schweiger C, Castelli D, Tramarin R, De Salvo M, Porcellati C, Giovagnoni F, Anniboletti PF, Calisti MG, Vergoni W, Iacopetti L, Zelaschi F, D'Cruz S, Lopizzo A, Caiazza M, Gigli G, Pastine J, Pulitanò G, Ruggeri A, Piovaccari G, Semprini P, Zavatteri G, Diaco T, Ceci V, Lumia F, Tamiz AM, Oliva G, Galati A, Picelli A, Picelli F, Bosco R, Marcellini G, Zanchè E, Martin G, Masutti S, Milani L, Pizzolato GM, Occhi G, Partesana N, Baldi N, Polimeni G, Furgi G, Nicolino A, Bevilacqua R, Ingignoli B, Massobrio N, Avogliero G, Pedretti R, Vaninetti R, Donnangelo L, Chiatto M, Gori P, Giannuzzi P, Temporelli PL, Fontanelli A, Garbin R.

Author information

1
Fondazione Salvatore Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico, Veruno, Italy. pantaleo.giannuzzi@fsm.it

Abstract

BACKGROUND:

Secondary prevention is not adequately implemented after myocardial infarction (MI). We assessed the effect on quality of care and prognosis of a long-term, relatively intensive rehabilitation strategy after MI.

METHODS:

We conducted a multicenter, randomized controlled trial in patients following standard post-MI cardiac rehabilitation, comparing a long-term, reinforced, multifactorial educational and behavioral intervention with usual care. A total of 3241 patients with recent MI were randomized to a 3-year multifactorial continued educational and behavioral program (intervention group; n = 1620) or usual care (control group; n = 1621). The combination of cardiovascular (CV) mortality, nonfatal MI, nonfatal stroke, and hospitalization for angina pectoris, heart failure, or urgent revascularization procedure was the primary end point. Other end points were major CV events, major cardiac and cerebrovascular events, lifestyle habits, and drug prescriptions.

RESULTS:

End point events occurred in 556 patients (17.2%). Compared with usual care, the intensive intervention did not decrease the primary end point significantly (16.1% vs 18.2%; hazard ratio [HR], 0.88; 95% confidence interval [CI], 0.74-1.04). However, the intensive intervention decreased several secondary end points: CV mortality plus nonfatal MI and stroke (3.2% vs 4.8%; HR, 0.67; 95% CI, 0.47-0.95), cardiac death plus nonfatal myocardial infarction (2.5% vs 4.0%; HR, 0.64; 95% CI, 0.43-0.94), and nonfatal MI (1.4% vs 2.7%; HR, 0.52; 95% CI, 0.31-0.86). A marked improvement in lifestyle habits (ie, exercise, diet, psychosocial stress, less deterioration of body weight control) and in prescription of drugs for secondary prevention was seen in the intervention group.

CONCLUSION:

The GOSPEL Study is the first trial to our knowledge to demonstrate that a multifactorial, continued reinforced intervention up to 3 years after rehabilitation following MI is effective in decreasing the risk of several important CV outcomes, particularly nonfatal MI, although the overall effect is small.

TRIAL REGISTRATION:

ClinicalTrials.gov Identifier: NCT00421876.

PMID:
19001195
DOI:
10.1001/archinte.168.20.2194
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center